Insiders · BOLT

BOLT insider transactions

Bolt Biotherapeutics Inc. (BOLT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for BOLT

• 123d
  President, CEO and CFO Quinn William P. bought $576 worth of shares (125 units at $4.61), increasing direct ownership by 6% to 2,313 units (SEC Form 4)

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 123d
  SEC Form 4 filed by Chief Operating Officer Yonehiro Grant

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 123d
  Senior VP, Finance and PAO Nemec Sarah bought $576 worth of shares (125 units at $4.61), increasing direct ownership by 10% to 1,415 units (SEC Form 4)

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 173d
  SEC Form 4 filed by Director Dupont Jakob

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 173d
  SEC Form 4 filed by Director Onetto Nicole

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 173d
  SEC Form 4 filed by Director Berner Laura

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 173d
  SEC Form 4 filed by Director Laporte Kathleen

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 173d
  SEC Form 4 filed by Director O'Callaghan Brian

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 173d
  SEC Form 4 filed by Senior VP, Finance and PAO Nemec Sarah

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 173d
  SEC Form 4 filed by Chief Operating Officer Yonehiro Grant

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 173d
  SEC Form 4 filed by President, CEO and CFO Quinn William P.

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 226d
  Senior VP, Finance and PAO Nemec Sarah was granted 23,000 shares and bought $686 worth of shares (125 units at $5.49), increasing direct ownership by 2,827% to 23,943 units (SEC Form 4)

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 226d
  Chief Operating Officer Yonehiro Grant was granted 30,000 shares, increasing direct ownership by 336% to 38,918 units (SEC Form 4)

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 226d
  President, CEO and CFO Quinn William P. bought $686 worth of shares (125 units at $5.49) and was granted 40,000 shares, increasing direct ownership by 1,945% to 42,188 units (SEC Form 4)

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 340d
  SEC Form 4 filed by Director Dupont Jakob

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 340d
  SEC Form 4 filed by Director Berner Laura

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 340d
  SEC Form 4 filed by Director Onetto Nicole

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 340d
  SEC Form 4 filed by Director Laporte Kathleen

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 340d
  SEC Form 4 filed by Director O'Callaghan Brian

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 398d
  SEC Form 4 filed by Director Dupont Jakob

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 398d
  SEC Form 4 filed by Chief Operating Officer Yonehiro Grant

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 398d
  Senior VP, Finance and PAO Nemec Sarah bought $2,835 worth of shares (5,000 units at $0.57), decreasing direct ownership by 2% to 13,863 units (SEC Form 4)

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 398d
  President, CEO and CFO Quinn William P. bought $2,835 worth of shares (5,000 units at $0.57) (SEC Form 4)

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 640d
  SEC Form 4 filed by Director Dupont Jakob

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 640d
  SEC Form 3 filed by new insider Dupont Jakob

  3 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 683d
  SEC Form 4 filed by Chief Operating Officer Yonehiro Grant

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 683d
  SEC Form 4 filed by President, CEO and CFO Quinn William P.

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 683d
  SEC Form 4 filed by VP, Finance and PAO Nemec Sarah

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 723d
  SEC Form 4 filed by Director Shah Mahendra

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 723d
  SEC Form 4 filed by Director Onetto Nicole

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 723d
  SEC Form 4 filed by Director O'Callaghan Brian

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 723d
  SEC Form 4 filed by Director Lee Frank D.

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 723d
  SEC Form 4 filed by Director Laporte Kathleen

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 723d
  SEC Form 4 filed by Director Healy James

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 723d
  SEC Form 4 filed by Director Berner Laura

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 753d
  New insider Nemec Sarah claimed ownership of 11,363 shares (SEC Form 3)

  3 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 823d
  SEC Form 4 filed by Yonehiro Grant

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 823d
  SEC Form 4 filed by Perez Edith A.

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 823d
  SEC Form 4 filed by Schatzman Randall C

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 823d
  SEC Form 4 filed by Quinn William P.

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 852d
  Yonehiro Grant bought $1,955 worth of shares (2,500 units at $0.78), increasing direct ownership by 39% to 8,918 units (SEC Form 5)

  5 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 852d
  Perez Edith A. bought $4,401 worth of shares (4,570 units at $0.96), increasing direct ownership by 11% to 46,612 units (SEC Form 5)

  5 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 852d
  Schatzman Randall C bought $4,909 worth of shares (5,000 units at $0.98), increasing direct ownership by 64% to 12,859 units (SEC Form 5)

  5 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 907d
  Quinn William P. bought $11,241 worth of shares (11,829 units at $0.95), increasing direct ownership by 48% to 36,272 units (SEC Form 4)

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 919d
  Engleman Edgar sold $128,993 worth of shares (148,884 units at $0.87) (SEC Form 4)

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 928d
  Engleman Edgar sold $1,751 worth of shares (1,943 units at $0.90) (SEC Form 4)

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 928d
  Vivo Capital Viii, Llc sold $3,060 worth of shares (3,400 units at $0.90) (SEC Form 4)

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 930d
  Engleman Edgar sold $45,675 worth of shares (49,173 units at $0.93) (SEC Form 4)

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 930d
  Vivo Capital Viii, Llc sold $7,636 worth of Comon Stock (8,211 units at $0.93) and sold $72,297 worth of shares (77,843 units at $0.93) (SEC Form 4)

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1089d
  SEC Form 4 filed by Shah Mahendra

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1089d
  SEC Form 4 filed by Onetto Nicole

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1089d
  SEC Form 4 filed by O'Callaghan Brian

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1089d
  SEC Form 4 filed by Miller Richard A Md

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1089d
  SEC Form 4 filed by Lee Frank D.

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1089d
  SEC Form 4 filed by Laporte Kathleen

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1089d
  SEC Form 4 filed by Healy James

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1089d
  SEC Form 4 filed by Engleman Edgar

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1089d
  SEC Form 4 filed by Berner Laura

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1195d
  SEC Form 4 filed by Yonehiro Grant

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1195d
  SEC Form 4 filed by Perez Edith A.

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)